American Board of Internal Medicine
MD, Northwestern Univ Medical School
BA, Northwestern University
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Infectious Disease
Mount Sinai Hospital
Solomon Silver Award in Clinical Medicine
Mount Sinai School of Medicine
Dr. Huprikar's research interest include solid organ transplantation in HIV-infected patients, the prevention and management of post-transplant CMV and fungal infections and resistant bacterial pathogens in transplant candidates and recipients.
Kubak BM, Huprikar SS. Emerging and Rare fungal infections in solid organ transplant recipients. AM J Transplant 2009 Dec; 9(4): S208-S226.
Huprikar S. RE: Effect of Prophylaxis on Fungal Infection and Costs for High-Risk Liver Transplant Recipients (letter). Liver Transplantation 2008 May; 14(5): 709.
Trindade AJ, Huysman A, Huprikar SS, Kim MK. A Case Study and Review of Pancreatitis in the AIDS Population. Dig Dis Sci 2008 Feb 21; Epub ahead of print.
Patel G, Arvelakis A, Sauther B, Gondolesi G, Caplivski D, Huprikar S. Case Report: Strongyloides Hyperinfection Syndrome after Intestinal Transplantation. Transpl Infect Dis 2008 Apr; 10(2): 137-141.
Huprikar S. Update in Infectious Diseases in Liver Transplant Recipients. Clin Liver Dis 2007 May; 11: 337-354.
Linden E, Restrepo D, Murphy B, Huprikar SS. Aspergillus Infection Limited to Renal Allograft: Case Report and Review of Literature. Transpl Infect Dis 2006 September; 8(3): 177-181.
Restrepo D, Huprikar SS, Vanhorn K, Bottone EJ. O1 and non-O1 Vibrio cholerae bacteremia produced by hemolytic strains. Diagn Microbiol Infect Dis 2006 February; 54(2): 145-148.
Caplivski D, Salama C, Huprikar SS, Bottone EJ. Disseminated histoplasmosis in five immunosuppressed patients: clinical, diagnostic, and therapeutic perspectives. Rev Med Micro 2005; 16: 1-7.
Dorell K, Cohen MA, Jones M, Huprikar SS, Gorman JM. Citalopram-induced diplopia. Psychosomatics 2005; 46: 91-93.
Sayegh SE, Keller MJ, Huprikar SS, Murphy B. Solid organ transplantation in HIV-infected recipients. Pediatr Transplant 2004 June; 8(3): 214-221.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Huprikar during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.